Late Effects of Small-Cell Lung Cancer Treatment

摘要: In the past prognosis of SCLC has been poor and, for most patients, long-term effects treatment have not a major concern. Few patients lived long enough to develop late treatment-related effects. Newer, safer treatments are now allowing people live longer. recent series, between 10% and 20% with limited-stage cured. The role prophylactic cranial irradiation after chemotherapy more clearly defined in years less serious than previously thought. important current include renal damage, neurotoxicities, pulmonary fibrosis. future biologic agents will almost certainly larger play management SCLC. As these introduced, response rates survival improve sequelae therapy become issue.